These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28615452)

  • 1. Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.
    Menezes SV; Sahni S; Kovacevic Z; Richardson DR
    J Biol Chem; 2017 Aug; 292(31):12772-12782. PubMed ID: 28615452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
    Menezes SV; Kovacevic Z; Richardson DR
    J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK; Fan X; Deng H; Zhang N; An Z
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
    Verma N; Müller AK; Kothari C; Panayotopoulou E; Kedan A; Selitrennik M; Mills GB; Nguyen LK; Shin S; Karn T; Holtrich U; Lev S
    Cancer Res; 2017 Jan; 77(1):86-99. PubMed ID: 27793840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer.
    Yang G; Huang L; Jia H; Aikemu B; Zhang S; Shao Y; Hong H; Yesseyeva G; Wang C; Li S; Sun J; Zheng M; Ma J
    Oncogene; 2021 Oct; 40(41):5993-6006. PubMed ID: 34385595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
    Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy.
    Bełtowski J; Jazmroz-Wiśniewska A
    Curr Pharm Des; 2014; 20(4):616-24. PubMed ID: 23688012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
    Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
    Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy.
    Zhong H; He J; Yu J; Li X; Mei Y; Hao L; Wu X
    Biochimie; 2021 Nov; 190():132-142. PubMed ID: 34293452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
    Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofibroblasts have an impact on expression, dimerization and signaling of different ErbB receptors in OSCC cells.
    Büttner R; Berndt A; Valkova C; Richter P; Korn A; Kosan C; Liebmann C
    J Recept Signal Transduct Res; 2017 Feb; 37(1):25-37. PubMed ID: 27051967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.
    Hart MR; Su HY; Broka D; Goverdhan A; Schroeder JA
    Mol Ther; 2013 Nov; 21(11):1996-2007. PubMed ID: 24081029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells.
    Menezes SV; Fouani L; Huang MLH; Geleta B; Maleki S; Richardson A; Richardson DR; Kovacevic Z
    Carcinogenesis; 2019 Jul; 40(6):805-818. PubMed ID: 30561520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for the pseudokinase HER3 in the acquired resistance against EGFR- and HER2-directed targeted therapy.
    Claus J; Patel G; Ng T; Parker PJ
    Biochem Soc Trans; 2014 Aug; 42(4):831-6. PubMed ID: 25109965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1.
    Wang B; Zhang J; Song F; Tian M; Shi B; Jiang H; Xu W; Wang H; Zhou M; Pan X; Gu J; Yang S; Jiang L; Li Z
    Cancer Lett; 2016 Oct; 381(2):331-40. PubMed ID: 27523281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 Activation Factors in Arsenite-Exposed Bladder Epithelial Cells.
    Jin P; Liu J; Wang X; Yang L; Zhou Q; Lin X; Xi S
    Toxicol Sci; 2018 Dec; 166(2):354-369. PubMed ID: 30137596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
    Brizzolara A; Benelli R; Venè R; Barboro P; Poggi A; Tosetti F; Ferrari N
    Cancer Lett; 2017 Aug; 400():9-17. PubMed ID: 28450158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.